ArticleDiscover oncology2026

A transcriptomic-based model associated with PARP inhibitor sensitivity and immunogenic signatures in ovarian cancer.

Xinxin Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.